Ashland Receives Remaining Regulatory Approvals Related to the Sale of its Composites Business and Butanediol Facility
The companies continue to expect a closing in the late summer of 2019.
Ashland Global Holdings Inc. recently announced that it has received the remaining regulatory approvals needed to close the previously announced sale of certain assets of Ashland’s Composites business and butanediol facility in Marl, Germany, to INEOS Enterprises Holdings Limited. Ashland and INEOS are reportedly working together to close the transaction as soon as possible in accordance with the Stock and Asset Purchase Agreement; the companies continue to expect a closing in the late summer of 2019.
Visit www.ashland.com and www.ineos.com for more information.
Looking for a reprint of this article?
From high-res PDFs to custom plaques, order your copy today!
